Streetbeat News

Stock Prices

FIS

Fidelity National Information Services (FIS) reported Q3 revenue of $2.489 billion, a 3% increase on a GAAP basis and 4% on an organic basis. The company's Q3 adjusted EPS of $1.65 beat the street view of $1.58. FIS also announced plans to repurchase approximately $500 million of shares in Q4 as part of a broader goal to repurchase at least $3.5 billion of shares by year-end 2024. Despite the positive earnings report, FIS shares are trading lower by 2.26% to $50.56.

Portfolio Pulse from Nabaparna Bhattacharya

November 07, 2023 | 4:23 pm

LVO

LiveOne has reiterated its guidance for FY24, expecting to add 800K-825K new paid members compared to the previous fiscal year.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 4:22 pm

DASH

UBER

Uber Technologies Inc (UBER) reported its second consecutive operating profit in Q3, with $9.3 billion in revenue, an 11% YoY increase. The company's mobility segment brought in $5.07 billion, food delivery contributed $2.93 billion, and the freight business added $1.28 billion. However, Q3 results were below LSEG’s estimate. Uber's rival, DoorDash Inc (DASH), also reported its best quarter since its IPO, with $2.2 billion in Q3 revenue, a YoY increase of 24%.

Portfolio Pulse from Upwallstreet

November 07, 2023 | 4:20 pm

HAIN

Hain Celestial Group Inc reported a Q1 FY24 sales decline of 3.3% YoY to $425.03 million, missing the analyst consensus estimate of $431.7 million. The decline was mainly due to lower sales in baby & kids products and challenges in organic formula supply. However, international net sales rose 9.3%. The company reaffirmed its FY24 organic net sales growth outlook of 2% to 4% and adjusted EBITDA of $155 million - $165 million.

Portfolio Pulse from Shivani Kumaresan

November 07, 2023 | 4:20 pm

SWAV

Shockwave Medical's shares are trading lower after the company released its Q3 earnings.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 4:18 pm

GILD

RCUS

Gilead Sciences Inc and Arcus Biosciences Inc announced positive preliminary results from their ongoing Phase 2 EDGE-Gastric study. The study evaluates the safety and efficacy of a combination cancer therapy involving domvanalimab, zimberelimab, and chemotherapy in patients with advanced gastric, gastroesophageal junction, or esophageal adenocarcinoma. The therapy showed encouraging overall response rate and six-month progression-free survival rate. The companies also have three ongoing Phase 3 studies of domvanalimab-containing regimens in lung cancer.

Portfolio Pulse from Vandana Singh

November 07, 2023 | 4:17 pm

DHI

D.R. Horton, Inc (NYSE:DHI) reported a 9% YoY sales growth in Q4 FY23, surpassing expectations. Net sales orders increased 39% YoY, while home sales revenues decreased by 6.4%. The company's EPS was $4.45, beating the consensus of $3.93. DHI also declared a 20% increase in its quarterly cash dividend. For FY24, DHI expects revenues between $36 billion and $37 billion, and repurchases of approximately $1.5 billion.

Portfolio Pulse from Akanksha Bakshi

November 07, 2023 | 4:15 pm

NOW

A significant number of investors have taken a bearish stance on ServiceNow (NYSE:NOW), with 70% of the observed trades being bearish. The big players have been eyeing a price window from $400.0 to $650.0 for ServiceNow during the past quarter. The stock's current price is $611.5, with an RSI indicating it may be approaching overbought. Analysts have mixed opinions, with ratings ranging from Buy to Market Outperform and price targets from $630 to $675.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 4:15 pm

FANG

A financial giant has made a bearish move on Diamondback Energy (NASDAQ:FANG), with 66% of traders showing bearish tendencies. The major market movers are focusing on a price band between $97.85 and $230.0 for Diamondback Energy. Analysts have mixed views, with Benchmark lowering its rating to Buy with a new price target of $154, while Susquehanna maintains a Positive rating with a target price of $200. Citigroup has revised its rating downward to Neutral, adjusting the price target to $170.

Portfolio Pulse from Benzinga Insights

November 07, 2023 | 4:15 pm

VGK

WFC

Wells Fargo has stated that a recession in the Eurozone is increasingly possible, although not yet inevitable. This could potentially impact the performance of the Vanguard FTSE Europe ETF (VGK), which tracks the performance of the European stock market.

Portfolio Pulse from Benzinga Newsdesk

November 07, 2023 | 4:15 pm